Neuronetics Community

NasdaqGM:STIM Community

1 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

TMS Acquisition And BMP Expansion Will Transform Treatment Delivery

Key Takeaways The acquisition of Greenbrook and expansion of the BMP program are expected to significantly boost revenue through increased patient access and operational efficiency. FDA clearance for adolescent treatment and improved insurance coverage will expand the market and increase revenue.

US$6.83

FV

40.4% undervalued

34.77%

Revenue growth p.a.

0

0

2

6 days ago